# Evaluating Customized Antibiotic Duration (CDA) Strategy in Acute Exacerbations of COPD

> **NCT07708337** · NA · NOT_YET_RECRUITING · sponsor: **Capital Development Authority (CDA)** · enrollment: 560 (estimated)

## Conditions studied

- COPD
- Acute Exacerbation of COPD

## Interventions

- **DRUG:** 7-day antibiotic course
- **DRUG:** 14-day antibiotic course

## Key facts

- **NCT ID:** NCT07708337
- **Lead sponsor:** Capital Development Authority (CDA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-26
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-02-28
- **Target enrollment:** 560 (ESTIMATED)
- **Last updated:** 2026-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708337, "Evaluating Customized Antibiotic Duration (CDA) Strategy in Acute Exacerbations of COPD". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07708337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*